Markets

Market

News Details

(29/01/2026 13:40)

Suven Life Sciences posts Q3 net loss of Rs 13.47 cr

The company reported standalone net loss during the quarter stood at Rs 13.47 crore as compared to net loss of Rs 13.27 crore in the previous year quarter.

Net revenue of the company rose substantially by 74.53 per cent at Rs 2.81 crore in October-December quarter of this fiscal as against Rs 1.61 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 18.71 per cent to Rs 17.70 crore from Rs 14.91 crore in year ago period.

Other Income grew by 76.43 per cent at Rs 2.77 crore versus (Dec'24 Rs 1.57 crore).

Operating Profit surged by 11.95 per cent to Rs -14.89 crore as against Rs -13.30 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 35.82 per cent in December quarter.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.